(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid

We are (Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid CAS:75028-24-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid
CAS.NO:75028-24-9
Synonyms:(Z)-1,2,3-trimethoxy-5-(4-methoxystyryl)benzene
(Z)-3,4,4',5-tetramethoxystilbene
(Z)-5-Amino-alpha-(ethoxyimino)-1,2,4-thiadiazole-3-acetic acid 
(Z)-1-[2-(4-methoxyphenyl)vinyl]-3,4,5-trimethoxybenzene
(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetic acid
Molecular Formula:C6H8N4O3S
Molecular Weight:216.21800
 
Specification:
Appearance:White to yellow powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For the synthesis of ceftaroline

(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid


Related News: It is delivered to hospitals and pharmacies until it reaches the patient.2-Chloro-6-nitrotoluene CAS:83-42-1 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.1,2,3,9-TETRAHYDRO-4H-9-METHYL-CARBAZOLE-4-ONE CAS:117290-74-1 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.9- (8-bromo-dibenzofuran-2-il) -9H-carbazol CAS:1100750-07-5 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.

Related Products
Product Name
Tetralin View Details
2,3-Difluorobenzyl bromide View Details
Ethyl 2-(2-formamidothiazol-4-yl)acetate View Details
2-Bromo-6-nitroaniline manufacturer Methyl 2-bromo-3-methylbutanoate manufacturer 4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridine-3-carboxamide manufacturer Glycine methyl ester hydrochloride manufacturer 18-crown-6 manufacturer